Shaohua Xu1,2, Yi Zhang1, Ying Yang1

  • 1Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.

PubMed
概括

对于预测肝肝细胞癌 (HCC) 瘤微环境 (TME) 和预后而言,mRNA N6-甲基氨酸 (m6A) 修饰模式至关重要. 根据预后,免疫类型和药物治疗,m6A风险评分为分层HCC患者提供了临床实用性.